文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

COVID-19 心脏骤停管理:急诊临床医生综述

COVID-19 cardiac arrest management: A review for emergency clinicians.
PubMed 文献 · Am J Emerg Med · 2020-08-17
一句话结论COVID-19 心脏骤停患者复苏需在标准流程基础上强调早期建立高级气道、严格感染控制与个人防护,并先评估复苏有效性再让人员暴露。

本文为叙述性综述,讨论 COVID-19 患者心脏骤停的病理生理与急诊管理策略,内容基于当前文献及对其他病原体经验的推演。COVID-19 患者可出现急性心肌损伤、心律失常和心脏骤停,危重患者死亡率高且随年龄和合并症增加。复苏与操作时须严格执行感染控制并优先通过适当使用个人防护装备保障医护人员安全,需在国家指南基础上联合新方法。指南变化强调早期放置高级气道以减少院内病毒传播,并鼓励在让人员暴露风险前先判断复苏措施的有效性。

要点

  • COVID-19 患者可出现急性心肌损伤、心律失常和心脏骤停,危重者死亡率高,且随年龄和合并症增加。
  • 对 COVID-19 心脏骤停患者行复苏和操作时,须严格执行感染控制措施,并通过适当使用个人防护装备优先保障医护人员自身安全。
  • 指南变化强调早期放置高级气道以限制院内病毒传播。
  • 指南鼓励医护人员在让人员面临暴露风险之前,先判断其复苏努力的有效性。
  • 治疗优先级和目标与疫情前相同,但 COVID-19 心脏骤停患者的管理与非 COVID-19 心脏骤停患者存在明显差异。

适用人群与场景

  • 急诊科场景中发生心脏骤停的 COVID-19 患者。

处置流程与药物剂量

  • 在提供复苏干预和进行操作时,医护人员须严格遵守感染控制措施,并通过适当使用个人防护装备优先保障自身安全。
  • 需在国家指南基础上联合实施新方法。
  • 指南变化强调早期放置高级气道以限制院内病毒传播。
  • 指南鼓励医护人员在让人员面临暴露风险之前,先判断其复苏努力的有效性。
  • 治疗优先级和目标与疫情前相同。
  • 综述还提供了团队构成的细节概述。

红旗征与不能漏的情况

  • COVID-19 患者可出现急性心肌损伤、心律失常和心脏骤停,危重患者死亡率高且随年龄和合并症增加。

研究设计与关键结果

  • 本文为叙述性综述,基于当前文献及对其他病原体经验的推演,讨论 COVID-19 患者心脏骤停的病理生理与急诊管理。
  • COVID-19 患者的心血管表现使其面临急性心肌损伤、心律失常和心脏骤停风险,危重患者死亡率高且随年龄和合并症增加。
  • 复苏与操作时须严格执行感染控制并优先通过适当使用个人防护装备保障医护人员安全,需在国家指南基础上联合新方法。
  • 指南变化强调早期放置高级气道以限制院内病毒传播,并鼓励在让人员暴露风险前判断复苏有效性。
  • 治疗优先级和目标与疫情前相同,但 COVID-19 心脏骤停患者的管理与非 COVID-19 患者存在明显差异。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对 COVID-19 心脏骤停患者,复苏时须在标准流程基础上严格执行感染控制并适当使用个人防护装备以保障医护人员安全。
  • 根据指南变化,应早期放置高级气道以限制院内病毒传播。
  • 根据指南,在让人员面临暴露风险之前应先判断复苏努力的有效性。
  • 治疗优先级和目标与疫情前相同,但管理与非 COVID-19 心脏骤停患者存在明显差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: A great deal of literature has recently discussed the evaluation and management of the coronavirus disease of 2019 (COVID-19) patient in the emergency department (ED) setting, but there remains a dearth of literature providing guidance on cardiac arrest management in this population.

OBJECTIVE: This narrative review outlines the underlying pathophysiology of patients with COVID-19 and discusses approaches to cardiac arrest management in the ED based on the current literature as well as extrapolations from experience with other pathogens.

DISCUSSION: Patients with COVID-19 may experience cardiovascular manifestations that place them at risk for acute myocardial injury, arrhythmias, and cardiac arrest. The mortality for these critically ill patients is high and increases with age and comorbidities. While providing resuscitative interventions and performing procedures on these patients, healthcare providers must adhere to strict infection control measures and prioritize their own safety through the appropriate use of personal protective equipment. A novel approach must be implemented in combination with national guidelines. The changes in these guidelines emphasize early placement of an advanced airway to limit nosocomial viral transmission and encourage healthcare providers to determine the effectiveness of their efforts prior to placing staff at risk for exposure.

CONCLUSIONS: While treatment priorities and goals are identical to pre-pandemic approaches, the management of COVID-19 patients in cardiac arrest has distinct differences from cardiac arrest patients without COVID-19. We provide a review of the current literature on the changes in cardiac arrest management as well as details outlining team composition.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ramzy M, Montrief T, Gottlieb M, et al. COVID-19 cardiac arrest management: A review for emergency clinicians. Am J Emerg Med. 2020. PMID: 33041141. doi:10.1016/j.ajem.2020.08.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。